Index S&P 500 P/E 48.96 EPS (ttm) 6.74 Insider Own 0.60% Shs Outstand 72.50M Perf Week 2.34%
Market Cap 23.79B Forward P/E 43.80 EPS next Y 7.54 Insider Trans -7.07% Shs Float 71.99M Perf Month -4.06%
Income 499.60M PEG 19.62 EPS next Q 1.72 Inst Own 96.40% Short Float 1.62% Perf Quarter 11.21%
Sales 2.88B P/S 8.27 EPS this Y -17.63% Inst Trans 0.03% Short Ratio 1.94 Perf Half Y -0.96%
Book/sh 37.96 P/B 8.69 EPS next Y 13.21% ROA 13.45% Short Interest 1.16M Perf Year -8.24%
Cash/sh 6.81 P/C 48.46 EPS next 5Y 2.50% ROE 17.78% 52W Range 265.00 - 413.70 Perf YTD -6.27%
Dividend Est. 0.81 (0.24%) P/FCF 73.97 EPS past 5Y 23.49% ROI 16.44% 52W High -20.22% Beta 1.00
Dividend TTM 0.81 (0.25%) Quick Ratio 2.23 Sales past 5Y 11.96% Gross Margin 35.00% 52W Low 24.55% ATR (14) 9.02
Dividend Ex-Date Nov 13, 2024 Current Ratio 3.00 EPS Y/Y TTM -9.46% Oper. Margin 20.73% RSI (14) 58.33 Volatility 2.51% 2.69%
Employees 10600 Debt/Eq 0.11 Sales Y/Y TTM -1.70% Profit Margin 17.37% Recom 1.92 Target Price 369.50
Option/Short Yes / Yes LT Debt/Eq 0.10 EPS Q/Q -13.50% Payout 9.90% Rel Volume 0.70 Prev Close 331.62
Sales Surprise 5.25% EPS Surprise 23.28% Sales Q/Q -0.08% Earnings Oct 24 BMO Avg Volume 600.54K Price 330.05
SMA20 3.29% SMA50 5.71% SMA200 0.07% Trades
Volume 422,534 Change -0.47%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-13-24 Initiated Wolfe Research
Peer Perform
Dec-12-24 Upgrade UBS
Neutral → Buy
$350 → $390
Feb-07-24 Upgrade Jefferies
Hold → Buy
$323 → $536
Jun-16-23 Upgrade BofA Securities
Neutral → Buy
$390 → $405
Apr-11-23 Upgrade Stephens
Equal-Weight → Overweight
$330 → $400
Dec-14-22 Initiated Deutsche Bank
Hold
$250
Nov-30-22 Initiated UBS
Neutral
$250
Oct-28-22 Downgrade BofA Securities
Buy → Neutral
$385 → $250
Nov-10-20 Initiated KeyBanc Capital Markets
Overweight
$350
Oct-14-20 Initiated Stephens
Equal-Weight
$300
Jul-21-20 Upgrade BofA Securities
Neutral → Buy
$280
Apr-24-20 Upgrade BofA/Merrill
Underperform → Neutral
$145 → $200
Dec-12-19 Downgrade BofA/Merrill
Neutral → Underperform
Jul-26-19 Upgrade BofA/Merrill
Underperform → Neutral
May-01-19 Downgrade Jefferies
Buy → Hold
$122
Apr-23-19 Initiated William Blair
Outperform
Apr-25-18 Downgrade BofA/Merrill
Neutral → Underperform
Jan-24-18 Initiated Goldman
Neutral
Oct-17-17 Downgrade BofA/Merrill
Buy → Neutral
Oct-03-17 Initiated Stephens
Equal-Weight
Show Previous Ratings
Today 06:45AM
Dec-13-24 08:00AM
Dec-11-24 06:00AM
Dec-10-24 09:31AM
Nov-27-24 09:04AM
10:12AM
Loading…
Nov-16-24 10:12AM
Oct-30-24 12:15PM
Oct-29-24 06:00AM
Oct-26-24 01:03AM
Oct-25-24 08:16AM
03:11AM
Oct-24-24 08:50PM
(Morningstar Research) +15.43%
05:12PM
01:09PM
07:10AM
06:07AM
Loading…
06:07AM
(Associated Press Finance)
06:00AM
Oct-22-24 12:02PM
06:00AM
Oct-17-24 10:01AM
Oct-10-24 06:00AM
Oct-09-24 06:00AM
Oct-07-24 09:54PM
06:00AM
Sep-18-24 05:15PM
Sep-05-24 06:00AM
Aug-29-24 07:06PM
(Morningstar Research) +5.77%
Aug-19-24 07:14AM
Jul-26-24 10:31AM
Jul-25-24 06:58PM
(Morningstar Research) -14.40%
09:50AM
Loading…
09:50AM
07:10AM
06:10AM
(Associated Press Finance)
06:00AM
Jul-22-24 09:51AM
Jul-17-24 04:01AM
Jul-11-24 06:00AM
Jun-21-24 01:37PM
Jun-13-24 07:02PM
Jun-06-24 02:31PM
02:25PM
May-29-24 06:00AM
May-28-24 06:00AM
May-24-24 04:57AM
May-09-24 03:43PM
Apr-30-24 09:19AM
06:00AM
Apr-29-24 07:40PM
Apr-27-24 01:07AM
Apr-26-24 11:34AM
11:07AM
10:56AM
03:12AM
Apr-25-24 10:31AM
09:12AM
08:34AM
07:10AM
07:02AM
06:43AM
06:08AM
(Associated Press Finance)
06:00AM
Apr-24-24 12:10PM
Apr-22-24 09:44AM
Apr-18-24 10:01AM
Apr-17-24 07:44AM
Apr-11-24 06:00AM
Apr-01-24 07:36AM
Mar-14-24 04:46PM
12:07PM
Mar-13-24 07:27PM
06:57AM
Mar-12-24 03:00PM
Feb-29-24 11:31PM
Feb-28-24 04:30PM
Feb-27-24 01:01PM
Feb-23-24 12:03AM
Feb-20-24 06:00AM
Feb-19-24 09:51AM
Feb-18-24 01:26PM
Feb-16-24 10:21AM
08:38AM
Feb-15-24 11:56PM
(Thomson Reuters StreetEvents) -14.08%
07:41PM
01:34PM
10:08AM
09:30AM
08:18AM
07:10AM
07:08AM
06:18AM
(Associated Press Finance)
06:00AM
Feb-13-24 08:57AM
Feb-12-24 09:16AM
Feb-07-24 07:33PM
08:00AM
Feb-01-24 06:00AM
Jan-22-24 10:33AM
06:51AM
Jan-04-24 06:41AM
Dec-06-23 06:00AM
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Witherspoon Charles VP & Treasurer Oct 29 '24 Option Exercise 173.22 478 82,799 1,956 Oct 31 12:05 PM Witherspoon Charles VP & Treasurer Oct 29 '24 Sale 310.40 703 218,211 1,253 Oct 31 12:05 PM Abraham Silji SVP, Chief Technology Officer Oct 29 '24 Option Exercise 0.00 458 0 3,318 Oct 31 11:50 AM Witherspoon Charles VP & Treasurer Aug 19 '24 Option Exercise 102.51 529 54,228 2,507 Aug 21 05:02 PM Witherspoon Charles VP & Treasurer Aug 19 '24 Sale 300.00 1,029 308,700 1,478 Aug 21 05:02 PM Hofmann Thomas W Director May 10 '24 Sale 365.92 617 225,773 43,565 Aug 21 04:51 PM Green Eric Mark President, CEO and Board Chair Aug 06 '24 Option Exercise 59.64 36,732 2,190,696 192,640 Aug 08 04:16 PM Green Eric Mark President, CEO and Board Chair Aug 06 '24 Sale 304.71 30,732 9,364,409 161,898 Aug 08 04:16 PM Green Eric Mark Officer Aug 06 '24 Proposed Sale 304.71 30,732 9,364,409 Aug 06 04:47 PM Abraham Silji SVP, Chief Technology Officer Jun 12 '24 Sale 330.78 1,800 595,404 2,860 Jun 13 04:46 PM Green Eric Mark President, CEO and Board Chair May 07 '24 Option Exercise 58.89 75,000 4,416,500 218,908 May 09 03:38 PM Green Eric Mark President, CEO and Board Chair May 07 '24 Sale 366.65 66,000 24,199,050 152,908 May 09 03:38 PM Winters Chad VP, Chief Accounting Officer Mar 11 '24 Option Exercise 173.22 675 116,924 2,124 Mar 12 11:46 AM Winters Chad VP, Chief Accounting Officer Mar 11 '24 Sale 358.82 815 292,436 1,309 Mar 12 11:46 AM Witherspoon Charles VP & Treasurer Feb 28 '24 Option Exercise 102.51 2,019 206,968 3,998 Mar 01 01:07 PM Witherspoon Charles VP & Treasurer Feb 28 '24 Sale 358.62 2,019 724,061 1,979 Mar 01 01:07 PM Green Eric Mark President, CEO and Board Chair Feb 27 '24 Option Exercise 57.38 73,132 4,196,314 217,040 Feb 29 04:35 PM Green Eric Mark President, CEO and Board Chair Feb 27 '24 Sale 359.85 64,132 23,077,971 152,908 Feb 29 04:35 PM Abraham Silji SVP, Chief Technology Officer Feb 23 '24 Option Exercise 173.22 7,012 1,214,619 11,672 Feb 27 11:37 AM Abraham Silji SVP, Chief Technology Officer Feb 23 '24 Sale 365.00 7,012 2,559,380 4,660 Feb 27 11:37 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
